Chemical Biology & Drug Design

Edited by:
Tomi K. Sawyer

Print ISSN: 1747-0277
Online ISSN: 1747-0285
Frequency: Monthly
Current Volume: 73 / 2009

Editorial Information

Editor-in-Chief
Tomi K. Sawyer, Aileron Therapeutics, Inc., USA
Tel: +1 617-995-2809
E-mail: editor@cbdd.org

CB&DD Editorial Office
Christine Molle - Editorial Assistant
christine.molle@cbdd.org
Telephone Number: +1 781-279-3784
Fax Number: +1 781-279-3785

Senior Editors
Fahad Al-Obeidi, Sanofi-Aventis, USA
Hagan Bayley, Oxford University, UK
Stephen Fesik, Abbott, USA
Richard Friesner, Columbia University, USA
Carlos Garcia-Echeverria, Novartis, Switzerland
Victor Hruby, University of Arizona, USA
Henry Mosberg, University of Michigan, USA
Mark Murcko, Vertex, USA
Juswinder Singh, Avila Therapeutics, USA
Joseph Vacca, Merck, USA
Gabriel Waksman, University College London/Birbeck College, UK
Zhong-Yin Zhang , Indiana University School of Medicine, USA

Editorial Internship Team
Justin Noehre, Aileron Therapeutics
Thomas Sawyer, Saint Michael's College
Osman A.B.S.M. Gani, University of Tromsø

Editorial Board
Dimitris Agrafiotis, Johnson & Johnson
Fernando Albericio, University of Barcelona
Marie-Isabel Aguilar, Monash University
Karl-Heinz Altmann, ETH (Swiss Federal Institute of Technology)
Dario Altieri, University of Massachusetts Medical School
Paul Aristoff, Pfizer
Peter Atadja, Novartis Institutes for Biomedical Research
Jeffrey Aube, University of Kansas
V.N. Balaji, Jubilant Biosys
Tadhg Begley, Cornell University
Padmanabhan Balaram, Indian Institute of Science
George Barany, University of Minnesota
Annette Beck-Sickinger, University of Liepzig
Ettore Benedetti, University of Naples
Tom Blundell, University of Cambridge
Regine Bohacek, Boston De Novo
Robert Bonomo, Case Western Reserve University
Jürgen Bajorath, University of Bonn
Diane Boschelli, Wyeth
Philip Burton, ADMETRx
Stephen Caddick, University College London
Heather Carlson, University of Michigan
Jean Chmielewski, Purdue University
Michael Chorev, Harvard Medical School
Tim Clackson, ARIAD Pharmaceuticals
Claude Cohen, Synergix
Peter Connolly, Johnson & Johnson
Eugene Cordes, Vitae Pharmaceuticals
David Corey, Southwestern Medical Center
Wendy Cornell, Merck Research Laboratories
David Craik, University of Queensland
David Dalgarno, ARIAD Pharmaceuticals
Ben Davis, University of Oxford
Charles Deber, University of Toronto
William DeGrado, University of Pennsylvania
Benoit DePrez, Institut Pasteur de Lille
Renee DesJarlais, Johnson & Johnson
Yuan-Hua Ding, Pfizer
Jonathan Ellman, University of California-Berkeley
Michael Eck, Harvard Medical School
Joseph Eyermann, Astra-Zeneca
David Fairlie, University of Queensland
Gregg Fields, Florida Atlantic University
Carol Fierke, University of Michigan
David Floyd, Pharmacopeia
Michael Foley, Infinity Pharmaceuticals
James Foster, University of North Dakota
Roger Freidinger, Merck Research Laboratories
Ernesto Freire, John Hopkins University
Bruce Ganem, Cornell University
Thomas Gardella, Massachusetts General Hospital
Jason Gestwicki, University of Michigan
Lila Gierasch, University of Massachusetts-Amherst
Brendan Gilmore, Queen's University
Michael Gilson, University of Maryland
Gary Glick, University of Michigan
Nathalie Goudreau, Boehringer-Ingelheim
Indraneel Ghosh, University of Arizona
Nathanael Gray, Dana Farber Cancer Institute
Paolo Grieco, University of Naples
Robert Gunther, University of Leipzig
Stephen Haggarty, Broad Institute, MIT
Philip Hajduk, Abbott Laboratories
Andrew Hamilton, Yale University
Heidi Hamm, Vanderbilt University
Robert Hammer, Louisiana State University
Patrick Harran, Southwestern Medical Center
Carrie Haskell-Luevano, University of Florida-Gainesville
Robert Heinrikson, Proteos
Bahram Hemmateenejad, Shiraz University
Paul Hergenrother, University of Illinois
Ralph Hirschmann, University of Pennsylvania
Robert Hodges, University of Colorado
Wim Hol, University of Washington
Barry Honig, Columbia University
Andrew Hopkins, University of Dundee
Richard Houghten, Torrey Pines Institute for Molecular Studies
Enoch Huang, Pfizer
Matt Jacobsen, University of California-San Francisco
Harren Jhoti, Astex Technology
David Jones, University College London
Natasha Kablaoui, Pfizer
Wieslaw Kazmierski, GlaxoSmithKline
Horst Kessler, Technical University-Munich
Alex Kiselyov, ChemDiv
Yoshiaki Kiso, Kyoto Pharmaceutical University
Gerhard Klebe, Philipps University
Ken Korzekwa, Merck Research Laboratories
Guido Kroemer, Institut Gustave-Roussy
Hugo Kubinyi, BASF
Cyrille Kuhn, Pfizer
Michael Lajiness, Eli Lilly & Company
Kit Lam, University of California-Davis
Joshua LeBaer, Harvard Medical School
Dominique Lessuise, Sanofi-Aventis
Guigen Li, Texas Tech University
Mark Lipton, Purdue University
Yan Luo, Abbott Laboratories
William Lubell, University of Montreal
Beth Lunney, Pfizer
Gerald Maggiora, University of Arizona
Bruce Maryanoff, Johnson & Johnson
Frank Mari, Florida Atlantic University
Garland Marshall, Washington University
Jean Martinez, Université Montpellier
Hans Matter, Sanofi-Aventis
Andy McCammon, University of California-San Diego
James McCarthy, Eli Lilly & Company
James McKerrow, University of California-San Francisco
Chester Metcalf III, Cubist Pharmaceuticals
Michael Michaelides, Abbott Laboratories
Dale Mierke, Brown University
Shahriar Mobashery, University of Notre Dame
Bradley Moore, University of Arizona
Andrew Mortlock, Astra-Zeneca
Steve Muchmore, Abbott Laboratories
Anil Nair, Sanofi-Aventis
Rick Neubig, University of Michigan
Gregory Nikiforoovich, Washington University
Richard Nugent, Pfizer
Robin Offord, University of Geneva
Michael Overduin, University of Birmingham
Robert Pearlstein, Novartis Institutes for Biomedical Research
Michael Pollastri, Boston University
Joseph Provost, Minnesota State University-Moorhead
Tariq Rana, University of Massachusetts Medical School
Todd Rockway, Abbott Laboratories
Bernard Roques, Université René Descartes
Vince Rotello, University of Massachusetts-Amherst
William Roush, Scripps-Florida
Leonard Rozamus, ARIAD Pharmaceuticals
Celia Schiffer, University of Massachusetts Medical School
Peter Schiller, University of Montreal
William Shakespeare, ARIAD Pharmaceuticals
Woody Sherman, Schrodinger
Yigong Shi, Princeton University
Sachdev Sidhu, University of Toronto
Adam Smith, Nobel Foundation
David Smith, Creighton University
Rob Stanton, Pfizer
Brian Stockman, Pfizer
Raji Sundaramoorthi, Chemistry Consultant
James Tam, Scripps University-Florida
Haile Techle, Pfizer
Suvit Thaisrivongs, Pfizer
Lynmarie Thompson, University of Massachusetts-Amherst
Claudio Toniolo, University of Padoa
Nicholas Turner, Manchester Interdisciplinary Biocenter
Greg Verdine, Harvard University
Michal Vieth, Eli Lilly & Company
Herbert Waldmann, Max Plank Institute
Dirk Tourwe, Vrije Universiteit Brussels
John Wade, University of Melbourne
Gerhard Wagner, Harvard University
Binghe Wang, Georgia State University
Yihan Wang, ARIAD Pharmaceuticals
James Wells, Sunesis & Univ California-San Franciscso
Manfred Weigele, Chemistry Advisor
Peter Wipf, University of Pittsburgh
Ronald Woodard, University of Michigan
Zhu-Jun Yao, Shanghai Institute of Organic Chemistry
Dennis Yamashita, GlaxoSmithKline
Xiaotian Zhu, ARIAD Pharmaceuticals